ロード中...
Treatment With Calcineurin Inhibitor FK506 Attenuates Noise-Induced Hearing Loss
Attenuation of noise-induced hair cell loss and noise-induced hearing loss (NIHL) by treatment with FK506 (tacrolimus), a calcineurin (CaN/PP2B) inhibitor used clinically as an immunosuppressant, has been previously reported, but the downstream mechanisms of FK506-attenuated NIHL remain unknown. Her...
保存先:
| 出版年: | Front Cell Dev Biol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7994600/ https://ncbi.nlm.nih.gov/pubmed/33777956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.648461 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|